Trial
NCT06381466
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Dilated Cardiomyopathy
Intervention
AZD0233
Why stopped
The study has been terminated due to adverse finding in a non-clinical, chronic toxicology study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-26